Literature DB >> 23575607

Inimitable Imatinib: the range of targeted tumours expands to include T-cell lymphoma.

S D Turner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23575607     DOI： 10.1038/leu.2012.304

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  3 in total

Review 1.  Molecular genetics of peripheral T-cell lymphomas.

Authors:  Pier Paolo Piccaluga; Valentina Tabanelli; Stefano A Pileri
Journal:  Int J Hematol       Date:  2014-01-31       Impact factor: 2.490

2.  Platelet-derived growth factor alpha mediates the proliferation of peripheral T-cell lymphoma cells via an autocrine regulatory pathway.

Authors:  P P Piccaluga; M Rossi; C Agostinelli; F Ricci; A Gazzola; S Righi; F Fuligni; M A Laginestra; M Mancini; M R Sapienza; A De Renzo; P L Tazzari; D Gibellini; P Went; F Alviano; P L Zinzani; G P Bagnara; G Inghirami; C Tripodo; S A Pileri
Journal:  Leukemia       Date:  2014-01-31       Impact factor: 11.528

3.  Angioimmunoblastic T-cell lymphoma and hypereosinophilic syndrome with FIP1L1/PDGFRA fusion gene effectively treated with imatinib: A case report.

Authors:  Masayo Yamamoto; Katsuya Ikuta; Yasumichi Toki; Mayumi Hatayama; Motohiro Shindo; Yoshihiro Torimoto; Toshikatsu Okumura
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.